Abington Neurological Associates

Abington, Pennsylvania 19090

3 studies enrolling now · 28 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Psychosis, Alzheimers Disease, Dementia, Early Alzheimer's Disease, Early Preclinical Alzheimer's Disease, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Narcolepsy, OSA, Preclinical Alzheimer's Disease

Studies at this site

• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
• Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease — Running, not enrolling
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• Observational Study of LUMRYZ in Narcolepsy — Completed
• A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD — Stopped early
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) — Running, not enrolling
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study of Semorinemab in Patients With Moderate Alzheimer's Disease — Completed
• TRC-PAD Program: In-Clinic Trial-Ready Cohort — Completed
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) — Stopped early
• A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD — Completed
• An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US — Stopped early
• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy — Completed